MARCHF5 and Parkinson disease: However, enhanced CMA inhibits the aggregation of DRP1 by promoting MARCH5 turnover, and reverses excessive mitochondrial fission under oxidative stress, thus alleviating the pathogenesis and progression of PD [19].